BioSpace News Archive

Urinary Catheters Market: Increasing Prevalence of Urinary Incontinence to Drive Urinary Catheters Market Growth

The urinary catheters market was valued at US$ 2,526.8 million in 2017 and it is projected to reach US$ 4,811.0 million in 2025; it is expected to grow at a CAGR of 8.6% from 2017 to 2025.

July 26, 2021
·
4 min read
Business

Kodiak Turns Down $125 Million Milestone Payment, Reducing Royalty Cap by Half

Kodiak Sciences, an ophthalmology-focused biotech company, based in Palo Alto, Calif., reportedly turned down $125 million from Baker Bros after hitting a clinical milestone. The company’s decision to decline this funding was due in part to its “strong balance sheet” and “clinical trial progress.”

July 26, 2021
·
2 min read
·
Brandon May
BioForest

Unmasking the SARS-CoV-2 Delta Variant: What We Know So Far

Just as it was beginning to appear safe to return to maskless, pre-pandemic life, the Delta variant of the SARS-CoV-2 virus emerged. It is fast-spreading, more likely to lead to hospitalizations, and accounts for most of the breakout infections among fully vaccinated individuals.

July 26, 2021
·
4 min read
·
Gail Dutton
Business

PerkinElmer Continues Rapid Life Science Growth with Massive $5.25B Acquisition

It’s been a long season of acquisitions for PerkinElmer. Now in its largest purchase ever, the Massachusetts-based company is dropping a massive $5.25 billion in cash and stock to buy biomedical research tool company BioLegend.

July 26, 2021
·
2 min read
·
Kate Goodwin
Drug Development

Allergan Eye Drops for Presbyopia Hits All Endpoints, Focuses In on Approval

The company said its Allergan eye drops met both its primary and key secondary endpoints, with patients reporting near and intermediate improvements in vision.

July 26, 2021
·
3 min read
·
Vanessa Doctor, RN
Drug Development

Abeona’s Gene Therapy for Rare Sanfilippo Syndrome Shines in Early Trials

Abeona Therapeutics’ shares popped 18.32% in pre-market trading after New York and Cleveland-based company announced magnetic resonance imaging (MRI) data from its Phase I/II Transpher A trial in San Filippo Syndrome Type A (MPS IIIA).

July 26, 2021
·
3 min read
·
Mark Terry
Business

Lantern, Allarity Come Together to Tackle Bladder, Prostate Cancer

Lantern will reacquire the Irofulven program and evaluate its potential for advanced development to treat bladder and prostate cancers.

July 26, 2021
·
2 min read
·
Vanessa Doctor, RN
Policy

Cross-Contamination of Medications is Wider Issue than Realized: Report

A recent report suggests that cross-contamination is not all that uncommon of an issue, and maybe inevitable.

July 26, 2021
·
2 min read
·
Alex Keown
Drug Development

BMS Withdraws Opdivo Liver Cancer Indication Following FDA Meeting

Bristol Myers Squibb (BMS) announced Friday its decision to withdraw from the U.S. market the indication for its immune checkpoint inhibitor Opdivo® (nivolumab) as monotherapy for hepatocellular carcinoma (HCC) in patients previously treated with sorafenib.

July 26, 2021
·
2 min read
·
Brandon May
Drug Development

FDA Rejects Incyte’s PD-1 For Anal Cancer, Requires More Proof of Benefit

The FDA’s ODAC met to discuss retifanlimab and voted 13-4 that a regulatory decision for the drug for this indication should be deferred until more data was available.

July 26, 2021
·
2 min read
·
Mark Terry